MAPT and Alzheimer disease: The peculiar potent aggregative ability and neurotoxicity of oAβ25–35, its capability to induce de novo the Aβ1–40/42 protein synthesis and the abnormal phosphorylation of Tau, now even discovered physiologically to be present in elderly people [14]–[16], reinforce its potential involvement in the pathogenesis of AD.